No Data
No Data
CARISMA THERAPEUTICS Earnings Preview: Recent $CARM Insider Trading, Hedge Fund Activity, and More
Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations
The Market Doesn't Like What It Sees From Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Revenues Yet As Shares Tumble 43%
BTIG Initiates Carisma Therapeutics(CARM.US) With Hold Rating
D. Boral Capital Initiates Carisma Therapeutics(CARM.US) With Buy Rating, Announces Target Price $1
12 Health Care Stocks Moving In Tuesday's Intraday Session